GLP-1 safety trends and emerging side effects While gastrointestinal discomfort is the most common issue, new safety signals continue to emerge
Designed explicitly for obesity intervention, Wegovy represents a focused approach to weight management, distinct from Mounjaros broader diabetes-centric inception
Ozempic is a brand-name semaglutide product, and it comes up constantly when people evaluate telehealth weight programs
Self-sourcing medications online or using products without medical supervision poses significant safety risks, particularly for individuals with existing endocrine conditions
Your prescribing doctor or pharmacist will recommend the best injection site for you
The decision to continue or discontinue Zepbound should weigh the benefits of weight loss against any mental health concerns, with patient safety and well-being as the primary consideration